Q517--Dallas Pharmacy Compounding-Oncology

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 is seeking chemotherapy preparation services for oncology patients at the North Texas Veterans Affairs Healthcare System in Dallas, Texas. The contractor must be a U.S.-based company capable of providing chemotherapy compounding services in CETA CAG certified primary and secondary engineering control environments, with the ability to deliver next-day prepared chemotherapy compounds. Technical requirements include preparing chemotherapeutic medications based on orders from VA Oncologists or Hematologists, providing daily shift reporting, and submitting monthly activity reports while maintaining strict quality assurance standards and compliance with Joint Commission standards and VA healthcare policies. The procurement will be evaluated as a competitive best-value acquisition considering technical capability, price, and past performance factors. Responses to this Request for Quote (RFQ 36C25726Q0033) are due by October 15, 2025, at 10:00 AM Central Time, with contract award anticipated shortly thereafter.

This solicitation does not utilize any set-aside designations and is open to all qualified contractors. The contract structure is a five-year Indefinite Delivery/Indefinite Quantity (IDIQ) arrangement with a base period from November 1, 2025, through October 31, 2026, followed by four additional option years. The contract has a minimum guaranteed value of $12,000 and a maximum aggregate value of $1,200,000 over the entire performance period. Services must be delivered to both the Dallas VA Medical Center and Garland VA Clinic, with the primary place of performance located at 4500 S Lancaster Rd, Dallas, TX 75216. The contractor will be required to process orders during specified service hours and maintain comprehensive pharmaceutical inventory capabilities, as evidenced by the extensive VA pricing schedule containing over 300 medical products including various chemotherapy drugs, IV solutions, and medical supplies.